Mayer, C., Brucker, J., Schütz, F., Domschke, C., Bechstein, S., Heil, J., . . . Rom, J. (2015). Efficacy and toxicity profile of pegylated liposomal doxorubicin in patients with advanced ovarian cancer. Archives of gynecology and obstetrics, 294(1), . https://doi.org/10.1007/s00404-015-3913-9
Chicago Style (17th ed.) CitationMayer, Christine, et al. "Efficacy and Toxicity Profile of Pegylated Liposomal Doxorubicin in Patients with Advanced Ovarian Cancer." Archives of Gynecology and Obstetrics 294, no. 1 (2015). https://doi.org/10.1007/s00404-015-3913-9.
MLA (9th ed.) CitationMayer, Christine, et al. "Efficacy and Toxicity Profile of Pegylated Liposomal Doxorubicin in Patients with Advanced Ovarian Cancer." Archives of Gynecology and Obstetrics, vol. 294, no. 1, 2015, https://doi.org/10.1007/s00404-015-3913-9.